5 results  1 of 1 

1 Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok, Christopher Wai Kei Lam
Endocrinol Metab.2021;36(2):279-295.   Published online 2021 April 19     DOI: http://dx.doi.org/10.3803/EnM.2021.964
      
2 Detection of Familial Hypercholesterolemia Using Next Generation Sequencing in Two Population-Based Cohorts
Hee Nam Kim, Sun-Seog Kweon, Min-Ho Shin
Chonnam Med J.2018;54(1):31-35.   Published online 2018 January 25     DOI: http://dx.doi.org/10.4068/cmj.2018.54.1.31
      
3 Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
Sang-Hak Lee
Endocrinol Metab.2017;32(1):36-40.   Published online 2017 January 19     DOI: http://dx.doi.org/10.3803/EnM.2017.32.1.36
   
4 Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Klaus G. Parhofer
Diabetes Metab J.2015;39(5):353-362.   Published online 2015 October 22     DOI: http://dx.doi.org/10.4093/dmj.2015.39.5.353
      
5 Sea Blue Histiocytosis Associated with Hyperlipoproteinemia Type IIb
Yoo Bock Lee, Hoguen Kim, Chan Il Park, Chung Sook Kim, In Joon Choi, Kir Young Kim, Young Hoe Moon
Yonsei Med J.1983;24(2):132-140.   Published online 2002 February 20     DOI: http://dx.doi.org/10.3349/ymj.1983.24.2.132
      

 1 of 1